Document is current
Any future updates will be listed below
-
Authors
Liao, Hao
Zhang, Jiayang
Zheng, Tiantian
Liu, Xiaoran
Zhong, Jianxin
Shao, Bin
Dong, Xiaoxi
Wang, Xiaohong
Du, Pan
King, Bonnie L.
Jia, Shidong
Yu, Jianjun
Li, Huiping http://orcid.org/0000-0002-3331-647X
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03792529 at ClinicalTrials.govDocuments that mention this clinical trial
Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients
https://doi.org/10.1186/s12967-022-03421-8
- License Information
-
More Information
Article History
Received: 31 August 2021
Accepted: 2 May 2022
First Online: 13 May 2022
Declarations
:
: All procedures performed in this study involving human participants were in accordance with the ethical standards of the Medical Ethics Committee of Peking University Cancer Hospital (No. 2020KT75). All patients signed a written informed consent prior to registration for ctDNA testing.
: Not applicable.
: The authors have no conflicts of interest to disclose.
